Alex joined SOSV in 2018 at the London-based life science program RebelBio and is now the program associate at IndieBio NY. Alex got his entrepreneurial start in 2016 at a boutique business consultancy startup in Philadelphia. In 2017, he joined Edelman London as the account executive at their pharmaceutical division, working alongside GlaxoSmithKline, Pfizer, and AstraZeneca.

Alex holds a BS in Biochemistry, Biophysics, and Molecular Biology from Imperial College London. He completed his Joint Honors in Business Management at Imperial Business School.